Peter Ghazal's research interests are aimed towards understanding how host-gene networks control infection, especially with those host-pathways associated with the immune-metabolic axis. Recent studies have been in the field of host genomics of early-life infection, mapping gene networks of systemic host response to infection and understanding the link between sterol metabolism and Interferon-host response. These studies are specifically aimed at the development of new diagnostic and therapeutic strategies, including predictive modelling of host-defence against infection, and the development of new computational and functional genomic methods for gaining a deeper understanding of complex dynamical biological systems.
Professor Ghazal is a founding member of the Genome-Wide RNAi Global Initiative, leading efforts on the development of Minimum Information About an RNAi Experiment, and is an active member of the Systems Biology Graphical Notation group. He has published over 190 refereed papers in first line journals, and has been a member on a number of advisory boards and committees within both academia and industry, and also for charitable and government bodies in the UK, EU, USA and Canada. He is presently Chair of the Virus Scientific Advisory Board for the Wellcome Trust Sanger Institute, and a member of the Scientific Advisory Board for the NIH NIAID Human Immunology Project Consortium.